Pharma

Mylan to Pay Abbott $5.3 Billion for Non-US Business

Belgium's Omega Pharma May Sell Itself

Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

Eli Lilly Copy of $8 Billion Sanofi Insulin Wins EU Approval

Pfizer-AstraZeneca Deal Still Occupies Analysts’ Fantasy

Merck KGaA and MorphoSys in Joint Antibody R&D

Former Novartis Employee Suspected of Data Manipulation

Topics • Strategy

Giving Pharma a Boost

Topics • Strategy

Opportunities Through Biotechnology

Alexion Recalls Certain Lots of Intravenous Drug Soliris

Novo Nordisk Launches Diabetes Drug in Germany After Rethink

Lilly and Sanofi Pursue OTC Status for Impotence Drug

New Valeant Bid Values Allergan at $49.44 Billion

Pfizer Abandons $118 billion AstraZeneca Takeover

AstraZeneca Rejects Pfizer’s ‘Final’ Takeover Offer

US Court Dismisses Teva Case to Block Generic Copaxone

AstraZeneca CEO ‘Would Engage With Pfizer’ for the Right Price

Valeant Says It Will Boost Allergan Bid

Allergan Rejects Valeant’s $47 Billion Bid as Shire Buys Lumena

Pfizer Hits Back at Criticis of Proposed AstraZeneca Deal

UK Prime Minister Calls on Pfizer for More Guarantees

Topics • Strategy

Devalued and Distrusted

Topics • Strategy

Evolution of a Dynamic Healthcare Market

Topics • Strategy

International Drugmakers Meet Challenges

UK May Use Public Interest Against Pfizer’s AstraZeneca Bid

Pfizer Ups Offer for AstraZeneca to $106 Billion

Merck Consumer Unit Said to be Worth $14 Billion for Bayer

Sanofi Said Eyeing Drug Divestments of Over $7 Billion

Pfizer Chases AstraZeneca for Potential $100 billion Deal

Actavis Sues FDA Over Generic of Pfizer’s Celebrex

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

Valeant, Ackman Make $47 billion offer for Allergan

Pfizer Said to be Interested in AstraZeneca

Novartis and Lilly Clinch Animal Health Deal

Novartis and GlaxoSmithKline Swap $20 Billion in Assets

143 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups

Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

PureTech Systems

GlaxoSmithKline (GSK) plc

Brenntag SE

SK Pharmteco

Porsche Consulting

Arthur D. Little

ARC Advisory Group GmbH & Co KG

Johnson & Johnson

Asahi Kasei Europe

Ontario Int. Marketing Ct.

Ofichem Group

LISA Life Science Austria

Universität Hohenheim - Institut für Lebensmitteltechnik

Thomson Reuters

Clariant International Ltd

Multivac Sepp Haggenmüller SE & Co. KG

Novartis International AG

Evonik Industries AG

Blue Sphere Health Ltd.

Cambrex Corporation

Symbiosis Pharmaceutical Services

IPCMF Irish Pharmaceut. & Chemical Manufacturers Fed.

Hongene Biotech

Farmindustria

Datamonitor Group

Helsinn Chemicals SA

gempex GmbH – THE GMP-EXPERT

WuXi AppTec

Veeva Systems

A.T. Kearney GmbH

Catalent Inc.

IMCD Group B.V.

Mack Brooks Exhibition Ltd – Part of RX

Oxford Instruments

Aenova Holding GmbH

PolarixPartner GmbH

Groupe Novasep